vidarabine has been researched along with Leukemia L 1210 in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (80.56) | 18.7374 |
| 1990's | 6 (16.67) | 18.2507 |
| 2000's | 1 (2.78) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capolongo, L; Cristalli, G; Eleuteri, A; Grifantini, M; Lupidi, G; Pesenti, E; Vittori, S; Volpini, R | 1 |
| Arnett, G; O'Dell, CA; Shealy, YF | 1 |
| Driscoll, JS; Kaskar, B; Khan, MS; Lim, MI; Markovac, A; Marquez, VE; Plowman, J; Priest, MA; Treanor, SP | 1 |
| Arnett, G; Clayton, JD; Shannon, WM; Shealy, YF | 1 |
| BRINK, JJ; LEPAGE, GA | 1 |
| King, I; Li, Z; Liu, L; Song, BL; Zheng, LM | 1 |
| Allaudeen, HS; Kozarich, JW; Sartorelli, AC | 1 |
| Brockman, RW; Cheng, YC; Montgomery, JA; Schabel, FM | 1 |
| Cass, CE; Phillips, JR; Selner, M | 1 |
| Cory, JG; Montgomery, JA; Sato, A | 1 |
| Egan, EM; Justi-Wheeler, H; Kufe, DW | 1 |
| Buchheit, DJ; Hong, CI; Kirisits, AJ; Nechaev, A; West, CR | 1 |
| Egan, M; Herrick, D; Kufe, DW; Major, PP; Munroe, D | 1 |
| Chello, PL; Dorick, DM; Montgomery, JA; Sirotnak, FM | 1 |
| Chello, PL; Dorick, DM; Montgomery, JA; Sirotnak, FM; Yang, CH | 1 |
| Cass, CE; Ferguson, PJ; Phillips, JR; Selner, M | 1 |
| Bennett, LL; Brockman, RW; Shaddix, SC; White, EL | 1 |
| Brockman, RW; El Dareer, SM; Hill, DL; Kirk, MC; Montgomery, JA; Shortnacy, AT; Struck, RF; Thorpe, MC | 1 |
| Hong, CI; MacCoss, M; Matsushita, T; Ryu, EK | 1 |
| Fabianowska-Majewska, K; Wyczechowska, D | 1 |
| Christian, R; Lee, SH; Sartorelli, AC; Unger, FM | 1 |
| Brockman, RW; Rose, LM | 1 |
| Brockman, RW; Montgomery, JA; Schabel, FM | 1 |
| Mittelman, A; Nechaev, A; Tritsch, GL | 1 |
| Caron, N; Kimball, AP; Lee, SH | 2 |
| Au-Yeung, TH; Cass, CE | 1 |
| Kimball, AP; LePage, GA; Worth, LS | 1 |
| Adjei, AA; Dagnino, L; Paterson, AR; Wong, MM | 1 |
| Belt, JA; Cass, CE; Dagnino, L; Gati, WP; Paterson, AR; Vijayalakshmi, D | 1 |
| Dagnino, L; Paterson, AR | 1 |
| Bennett, LL; Dagnino, L; Paterson, AR | 1 |
| Kawakami, T; Komiyama, K; Omura, S; Tanaka, H; Yang, ZB | 1 |
| Barrueco, JR; Brockman, RW; Chang, CH; Jacobsen, DM; Sirotnak, FM | 1 |
| Bacon, PE; Brown, NC; Carter, GL; Cory, JG; Montgomery, JA; Sato, A | 1 |
| Kufe, DW; Spriggs, DR | 1 |
1 review(s) available for vidarabine and Leukemia L 1210
| Article | Year |
|---|---|
Biochemical and cellular pharmacology of cytosine arabinoside.
Topics: Animals; Aphidicolin; Arabinofuranosylcytosine Triphosphate; Binding, Competitive; Cell Line; Cell Survival; Centrifugation, Density Gradient; Cytarabine; Diterpenes; DNA; DNA Repair; DNA Replication; Fibroblasts; Granulocytes; Humans; Kinetics; Leukemia L1210; Leukemia, Myeloid, Acute; Nucleic Acid Synthesis Inhibitors; Templates, Genetic; Vidarabine | 1985 |
35 other study(ies) available for vidarabine and Leukemia L 1210
| Article | Year |
|---|---|
Purine and 1-deazapurine ribonucleosides and deoxyribonucleosides: synthesis and biological activity.
Topics: Adenosine Deaminase Inhibitors; Animals; Antineoplastic Agents; Cattle; Chemical Phenomena; Chemistry; Deoxyribonucleosides; Drug Synergism; Female; Leukemia L1210; Leukemia P388; Mice; Mice, Inbred BALB C; Purines; Ribonucleosides; Structure-Activity Relationship | 1991 |
Synthesis and antiviral evaluation of carbocyclic analogues of 2-amino-6-substituted-purine 3'-deoxyribofuranosides.
Topics: Animals; Antiviral Agents; Arabinonucleosides; Humans; Leukemia L1210; Mice; Orthomyxoviridae; Simplexvirus | 1987 |
Cyclopentenylcytosine. A carbocyclic nucleoside with antitumor and antiviral properties.
Topics: 3-Deazauridine; Animals; Antineoplastic Agents; Antiviral Agents; Chemical Phenomena; Chemistry; Cytidine; DNA Viruses; Humans; Leukemia L1210; Leukemia P388; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Orthomyxoviridae; RNA Viruses; Sarcoma, Experimental; Viruses | 1988 |
Synthesis and antiviral evaluation of carbocyclic analogues of ribofuranosides of 2-amino-6-substituted-purines and of 2-amino-6-substituted-8-azapurines.
Topics: Adenosine; Animals; Antiviral Agents; Drug Evaluation, Preclinical; Indicators and Reagents; Leukemia L1210; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Purine Nucleosides; Simplexvirus; Spectrophotometry; Structure-Activity Relationship; Vaccinia virus | 1984 |
METABOLISM AND DISTRIBUTION OF 9-BETA-D-ARABINOFURANOSYLADENINE IN MOUSE TISSUES.
Topics: Animals; Antineoplastic Agents; DNA; DNA, Neoplasm; Leukemia L1210; Leukocytes; Liver; Mice; Neoplasms; Neoplasms, Experimental; Nucleosides; Pharmacology; Research; RNA; RNA, Neoplasm; Urine; Vidarabine | 1964 |
Anti-tumor efficacy of Cloretazine (VNP40101M) alone and in combination with fludarabine in murine tumor and human xenograft tumor models.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Hydrazines; Injections, Intraperitoneal; Leukemia L1210; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Sulfonamides; Survival Analysis; Time Factors; Tumor Burden; Vidarabine; Weight Loss; Xenograft Model Antitumor Assays | 2007 |
Comparative effects of the 5'-triphosphates of 9-beta-(2'-azido-2'-deoxy-D-arabinofuranosyl)adenine and 9-beta-D-arabinofuranosyladenine on DNA polymerases from L1210 leukemia cells.
Topics: Animals; Arabinonucleotides; DNA Polymerase I; DNA Polymerase II; DNA-Directed DNA Polymerase; Kinetics; Leukemia L1210; Mice; Vidarabine; Vidarabine Phosphate | 1982 |
Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
Topics: Animals; Cell Line; Chromatography, DEAE-Cellulose; Deoxycytidine Kinase; DNA; Electrophoresis, Polyacrylamide Gel; Leukemia L1210; Mice; Mutation; Oxidative Phosphorylation; Phosphotransferases; Vidarabine | 1980 |
Resistance to 9-beta-D-arabinofuranosyladenine in cultured leukemia L 1210 cells.
Topics: Adenosine Kinase; Animals; Cell Division; Coformycin; DNA Replication; Drug Resistance; Leukemia L1210; Mice; Pentostatin; Tubercidin; Vidarabine | 1983 |
Synergistic inhibition of leukemia L1210 cell growth in vitro by combinations of 2-fluoroadenine nucleosides and hydroxyurea or 2,3-dihydro-1H-pyrazole[2,3-a]imidazole.
Topics: Animals; Cell Survival; Cytidine; Deferoxamine; Deoxyadenosines; Deoxycytidine; Drug Synergism; Hydroxyurea; Kinetics; Leukemia L1210; Mice; Pyrazoles; Vidarabine | 1984 |
Alkali lability of deoxyribonucleic acid that contains adenine arabinoside.
Topics: Alkalies; Animals; Cells, Cultured; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; DNA, Neoplasm; Leukemia L1210; Mice; Vidarabine | 1983 |
Nucleoside conjugates V: Synthesis and biological activity of 9-(beta-D-arabinofuranosyl)adenine conjugates of corticosteroids.
Topics: Adenosine Deaminase; Animals; Antineoplastic Agents; Cell Division; Chemical Phenomena; Chemistry, Physical; Glucocorticoids; Hydrolysis; Leukemia L1210; Mice; Vidarabine | 1984 |
Relationship between incorporation of 9-beta-D-arabinofuranosyladenine in L 1210 DNA and cytotoxicity.
Topics: Animals; Cell Survival; Cells, Cultured; Centrifugation, Density Gradient; Chromatography, High Pressure Liquid; DNA, Neoplasm; Dose-Response Relationship, Drug; Leukemia L1210; Mice; RNA, Neoplasm; Vidarabine | 1983 |
Specificity of systems mediating transport of adenosine, 9-beta-d-arabinofuranosyl-2-fluoroadenine, and other purine nucleoside analogues in L1210 cells.
Topics: Adenosine; Animals; Biological Transport; Kinetics; Leukemia L1210; Mice; Purine Nucleosides; Temperature; Time Factors; Vidarabine | 1983 |
Initial rate kinetics and evidence for duality of mediated transport of adenosine, related purine nucleosides, and nucleoside analogues in L1210 cells.
Topics: Adenosine; Animals; Biological Transport; Cell Membrane; Kinetics; Leukemia L1210; Mice; Purine Nucleosides; Temperature; Time Factors; Vidarabine | 1983 |
Effects of 2'-deoxyadenosine, 9-beta-D-arabinofuranosyladenine, and related compounds on S-adenosyl-L-homocysteine hydrolase activity in synchronous and asynchronous cultured cells.
Topics: Adenosylhomocysteinase; Animals; Cell Cycle; Deoxyadenosines; HeLa Cells; Humans; Hydrolases; Kinetics; Leukemia L1210; Mice; Vidarabine | 1982 |
Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
Topics: Adenosylhomocysteinase; Animals; DNA Polymerase I; DNA Polymerase II; DNA Replication; Hydrolases; Leukemia L1210; Mice; Nucleic Acid Synthesis Inhibitors; Ribonucleotide Reductases; Vidarabine | 1982 |
Identification of metabolites of 9-beta-D-arabinofuranosyl-2-fluoroadenine, an antitumor and antiviral agent.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Chemical Phenomena; Chemistry; Dogs; Female; Leukemia L1210; Macaca mulatta; Male; Mice; Vidarabine | 1982 |
Phospholipid derivatives of nucleoside analogs as prodrugs with enhanced catabolic stability.
Topics: Animals; Biotransformation; Cell Division; Cell Line; Cytarabine; Cytidine Diphosphate Diglycerides; Deamination; Delayed-Action Preparations; Injections, Intraperitoneal; Leukemia L1210; Mice; Neoplasm Transplantation; Prognosis; Ribonucleosides; Technology, Pharmaceutical; Tubercidin; Vidarabine | 1981 |
Does 2-chlorodeoxyadenosine contribute to alteration of DNA methyltransferase activity?
Topics: Adenosylhomocysteinase; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Cladribine; Decitabine; DNA (Cytosine-5-)-Methyltransferases; Hydrolases; Kinetics; Leukemia L1210; Mice; Tumor Cells, Cultured; Vidarabine | 1998 |
Cytotoxic activity of the adenine arabinoside analogs, 2'-azido- and 2'-amino-2'-deoxy-beta-D-arabinofuranosyladenine.
Topics: Adenosine Deaminase; Animals; Antineoplastic Agents; Cattle; Cell Division; In Vitro Techniques; Intestinal Mucosa; Leukemia L1210; Substrate Specificity; Vidarabine | 1979 |
Analysis by high-pressure liquid chromatography of 9-beta-D-arabinofuranosyladenine 5'-triphosphate levels in murine leukemia cells.
Topics: Adenosine Deaminase Inhibitors; Adenosine Triphosphate; Animals; Arabinose; Chromatography, High Pressure Liquid; Leukemia L1210; Vidarabine | 1977 |
Biologic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-beta-D-arabinofuranosyladenine.
Topics: Animals; Cells, Cultured; DNA, Neoplasm; Leukemia L1210; Mice; Time Factors; Vidarabine | 1977 |
Synergism between the antiproliferative activities of arabinosyladenine and N6-benzyladenosine.
Topics: Adenosine; Adenosine Deaminase Inhibitors; Animals; Cell Division; Cells, Cultured; Drug Synergism; Drug Therapy, Combination; Leukemia L1210; Vidarabine | 1977 |
Therapeutic effects of 9-beta-D-arabinofuranosyladenine and 2'-deoxycoformycin combinations on intracerebral leukemia.
Topics: Adenosine Deaminase Inhibitors; Animals; Antineoplastic Agents; Azepines; Brain Neoplasms; Deoxyribonucleosides; Drug Therapy, Combination; Female; Leukemia L1210; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Nucleoside Deaminases; Vidarabine | 1977 |
Effects of 2'-deoxycoformycin, 9-beta-D-arabinofuranosyladenine 5'-phosphate, and 1-beta-D-arabinofuranosylcytosine triple combination therapy on intracerebral leukemia 1210.
Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Antineoplastic Agents; Azepines; Body Weight; Brain; Brain Neoplasms; Cytarabine; Deoxyribonucleotides; Drug Synergism; Drug Therapy, Combination; Female; In Vitro Techniques; Kinetics; Leukemia L1210; Mice; Mice, Inbred DBA; Vidarabine | 1977 |
Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin.
Topics: Adenosine Deaminase Inhibitors; Animals; Azepines; Cells, Cultured; Deoxyribonucleosides; DNA, Neoplasm; Drug Synergism; Leukemia L1210; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Proteins; Purine Nucleosides; RNA, Neoplasm; Vidarabine | 1976 |
Enhancement of the antitumor activity of arabinofuranosyladenine of 2'-deoxycoformycin.
Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Azepines; Cytarabine; Deoxyribonucleosides; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Female; Leukemia L1210; Lymphoma, Non-Hodgkin; Mice; Mice, Inbred Strains; Purine Nucleosides; Sarcoma, Experimental; Vidarabine | 1976 |
Protection against fludarabine neurotoxicity in leukemic mice by the nucleoside transport inhibitor nitrobenzylthioinosine.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Female; Hindlimb; Leukemia L1210; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Nervous System Diseases; Paralysis; Prodrugs; Thioinosine; Thionucleotides; Vidarabine | 1992 |
L1210/B23.1 cells express equilibrative, inhibitor-sensitive nucleoside transport activity and lack two parental nucleoside transport activities.
Topics: Adenine; Adenosine; Animals; Antiviral Agents; Biological Transport; Carrier Proteins; Cell Membrane; Clone Cells; Formycins; Kinetics; Leukemia L1210; Membrane Proteins; Mice; Mutagenesis; Nucleoside Transport Proteins; Nucleosides; Thioinosine; Thymidine; Tumor Cells, Cultured; Vidarabine | 1992 |
Sodium-dependent and equilibrative nucleoside transport systems in L1210 mouse leukemia cells: effect of inhibitors of equilibrative systems on the content and retention of nucleosides.
Topics: Animals; Biological Transport; Dilazep; Dipyridamole; Formycins; Leukemia L1210; Mice; Nucleosides; Sodium; Thioinosine; Vidarabine; Vidarabine Phosphate | 1990 |
Substrate specificity, kinetics, and stoichiometry of sodium-dependent adenosine transport in L1210/AM mouse leukemia cells.
Topics: 4-Chloromercuribenzenesulfonate; Adenosine; Animals; Biological Transport; Ethylmaleimide; Kinetics; Leukemia L1210; Mice; Showdomycin; Sodium; Substrate Specificity; Temperature; Tumor Cells, Cultured; Vidarabine | 1991 |
Potentiation of cytotoxicity and antitumor activity of adenosine analogs by the adenosine deaminase inhibitor adecypenol.
Topics: Adenosine; Adenosine Deaminase Inhibitors; Animals; Antineoplastic Agents; Cyclopentanes; Deoxyadenosines; Drug Synergism; HeLa Cells; Humans; Leukemia L1210; Mice; Molecular Structure; Nucleoside Deaminases; Purines; Vidarabine | 1989 |
Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells.
Topics: Animals; Biological Transport; Epithelium; Intestine, Small; Kinetics; Leukemia L1210; Mice; Mice, Inbred Strains; Organ Specificity; Phosphorylation; Tritium; Vidarabine | 1987 |
The utility of combinations of drugs directed at specific sites of the same target enzyme--ribonucleotide reductase as the model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cells, Cultured; Deoxyadenosines; Deoxyguanosine; Hydroxyurea; Isoquinolines; Leukemia L1210; Models, Biological; Nucleic Acid Synthesis Inhibitors; Phosphorylases; Pyrazoles; Ribonucleoside Diphosphate Reductase; Ribonucleotide Reductases; Thymidine; Vidarabine | 1985 |